These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 18180653)
21. The WATCHMAN device for stroke prophylaxis in atrial fibrillation: an evolving niche. Couch G; Sabir I Hosp Pract (1995); 2015; 43(1):13-21. PubMed ID: 25559429 [TBL] [Abstract][Full Text] [Related]
22. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D; Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525 [TBL] [Abstract][Full Text] [Related]
23. Self-expandable device for percutaneous closing of left atrial appendage with organized thrombus in a patient with permanent atrial fibrillation. Pak HN; Shim CY; Kim JS; Park JW; Jang Y Can J Cardiol; 2013 Oct; 29(10):1329.e1-1329.e3. PubMed ID: 23228490 [TBL] [Abstract][Full Text] [Related]
24. Left atrial appendage closure: a new technique for clinical practice. John Camm A; Colombo A; Corbucci G; Padeletti L Heart Rhythm; 2014 Mar; 11(3):514-21. PubMed ID: 24291776 [TBL] [Abstract][Full Text] [Related]
25. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke]. Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805 [TBL] [Abstract][Full Text] [Related]
26. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience. Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325 [TBL] [Abstract][Full Text] [Related]
27. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. Viles-Gonzalez JF; Reddy VY; Petru J; Mraz T; Grossova Z; Kralovec S; Neuzil P J Interv Card Electrophysiol; 2012 Jan; 33(1):69-75. PubMed ID: 21947786 [TBL] [Abstract][Full Text] [Related]
29. Atrial fibrillation and stroke management: present and future. Holmes DR Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a novel device for left atrial appendage exclusion: the second-generation atrial exclusion device. Kamohara K; Fukamachi K; Ootaki Y; Akiyama M; Cingoz F; Ootaki C; Vince DG; Popović ZB; Kopcak MW; Dessoffy R; Liu J; Gillinov AM J Thorac Cardiovasc Surg; 2006 Aug; 132(2):340-6. PubMed ID: 16872960 [TBL] [Abstract][Full Text] [Related]
31. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation. Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999 [No Abstract] [Full Text] [Related]
32. WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation: a percutaneous-device delivery approach. Lerakis S; Synetos A Future Cardiol; 2007 Sep; 3(5):507-9. PubMed ID: 19804304 [TBL] [Abstract][Full Text] [Related]
33. A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device. Fumoto H; Gillinov AM; Ootaki Y; Akiyama M; Saeed D; Horai T; Ootaki C; Vince DG; Popović ZB; Dessoffy R; Massiello A; Catanese J; Fukamachi K J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1019-27. PubMed ID: 18954645 [TBL] [Abstract][Full Text] [Related]
34. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Gangireddy SR; Halperin JL; Fuster V; Reddy VY Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509 [TBL] [Abstract][Full Text] [Related]
35. Percutaneous left atrial appendage occlusion with a Watchman device following recurrent stroke on warfarin and rivaroxaban in patient with paroxysmal atrial fibrillation. Spina R; Subbiah R; Markus R; Gunalingam B Heart Lung Circ; 2014 Feb; 23(2):171-3. PubMed ID: 24076164 [TBL] [Abstract][Full Text] [Related]
36. Left Atrial Appendage and Closure: Who, When, and How. Holmes DR; Reddy VY Circ Cardiovasc Interv; 2016 May; 9(5):e002942. PubMed ID: 27139910 [TBL] [Abstract][Full Text] [Related]
37. Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients. Khattab AA; Meier B Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):819-21. PubMed ID: 22908912 [No Abstract] [Full Text] [Related]
38. A novel approach to left atrial appendage exclusion: the WATCHMAN device. Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study. Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217 [TBL] [Abstract][Full Text] [Related]
40. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Le D; Morelli R; Badhwar N; Lee RJ Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]